Orthopedics
Page 1 • 3 itemsGain critical insights into global orthopedic drug development, market trends, and regulatory landscapes. Inform your pharma strategy.
Theradaptive Receives FDA Approval for Pivotal Phase 3 Trial of OsteoAdapt SP in Spinal Fusion
Theradaptive advances OsteoAdapt SP bone regeneration therapy to pivotal Phase 3 OASIS trial for spinal fusion after FDA approval milestone.
CGBIO Receives FDA 510(k) Clearance for EASYMADE TI Patient-Specific Titanium Implant
CGBIO becomes first Korean company to receive FDA 510(k) clearance for patient-specific titanium implant EASYMADE TI, marking regulatory milestone.
Cerapedics Secures Vizient Supplier Agreement for PearlMatrix P-15 Bone Graft Treatment
Cerapedics partners with Vizient to expand access to PearlMatrix P-15 Peptide Enhanced Bone Graft for lumbar spine degenerative disc disease treatment.